The effects of pituitary adenylate cyclase activating polypeptide in renal ischemia/reperfusion

László, Eszter and Kiss, Péter and Horváth, Gabriella and Szakály, Péter and Tamás, Andrea and Reglődi, Dóra (2014) The effects of pituitary adenylate cyclase activating polypeptide in renal ischemia/reperfusion. ACTA BIOLOGICA HUNGARICA, 65 (4). pp. 369-378. ISSN 0236-5383

[img] Text
the effects of pacap in renal ischemia_reperfusion.pdf
Restricted to Repository staff only until 31 December 2034.

Download (827kB) | Request a copy


Pituitary adenylate cyclase activating polypeptide (PACAP ) is a multifunctional neuropeptide occurring in the nervous system as well as in the peripheral organs. Beneficial action of PACAP has been shown in different pathological processes. The strong protective effects of the peptide are probably due to its complex modulatory actions in antiapoptotic, anti-inflammatory and antioxidant pathways. In the kidney, PACAP is protective in models of diabetic nephropathy, myeloma kidney injury, cisplatin-, gentamycinand cyclosporin-induced damages. Numerous studies have been published describing the protective effect of this peptide in renal ischemia/reperfusion. The present review focuses on the ischemia/reperfusioninduced kidney injury and gives a brief summary about the results published in this area.

Item Type: Article
Uncontrolled Keywords: kidney, ischemia/reperfusion, PACAP, renoprotection
Subjects: R Medicine / orvostudomány > R1 Medicine (General) / orvostudomány általában
Depositing User: Dr. Gabriella Horváth-Opper
Date Deposited: 16 Sep 2015 13:54
Last Modified: 14 Sep 2018 07:13

Actions (login required)

Edit Item Edit Item